綠城管理控股(09979.HK)獲執行董事兼執行總裁林三九增持9萬股
格隆匯8月17日丨綠城管理控股(09979.HK)發佈公吿,董事會獲執行董事、執行總裁林三九吿知,2022年8月16日,林三九於市場以平均價格每股6.1922港元增持9萬股股份,總代價約為55.73萬港元(不包括相關交易費)。
緊隨增持事項後,林三九自公司上市日期(即2020年7月10日)起至該公吿日期止,累積個人持有共153萬股股份,同時他擁有公司未歸屬的344萬股獎勵股份。因此,林三九於公司實際擁有的權益為497萬股,佔已發行股本約0.25%。林三九表示對公司整體發展前景及增長潛力具有信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.